U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06979973) titled 'A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants' on May 09.
Brief Summary: Phase 1, open-label, non-randomized, three-treatment, one-sequence interaction study to evaluate the PK interactions between CKD-508, midazolam, and rosuvastatin in healthy adult male participants
Study Start Date: May 14
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Midazolam
midazolam syrup
DRUG: Rosuvastatin
Rosuvastatin
DRUG: CKD-508 Tablet
CKD-508
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Chong Kun Dang Pharm...